Odysight.ai Inc. (ODYS)
NASDAQ: ODYS · Real-Time Price · USD
5.20
0.00 (0.00%)
Jun 6, 2025, 4:00 PM - Market closed
Odysight.ai Revenue
Odysight.ai had revenue of $2.07M in the quarter ending March 31, 2025, with 1,004.28% growth. This brings the company's revenue in the last twelve months to $5.84M, up 100.27% year-over-year. In the year 2024, Odysight.ai had annual revenue of $3.96M with 30.70% growth.
Revenue (ttm)
$5.84M
Revenue Growth
+100.27%
P/S Ratio
11.11
Revenue / Employee
$95,770
Employees
61
Market Cap
84.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Apple | 400.37B |
Microsoft | 270.01B |
NVIDIA | 148.52B |
Taiwan Semiconductor Manufacturing Company | 94.40B |
Broadcom | 57.05B |
Oracle | 55.78B |
Cisco Systems | 55.62B |
Salesforce | 38.59B |
ODYS News
- 24 days ago - Odysight.ai Reports Financial Results for The First Quarter of 2025 and Provides Business Update - GlobeNewsWire
- 2 months ago - Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry - GlobeNewsWire
- 2 months ago - Odysight.ai Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Odysight.ai to Participate at the 37th Annual ROTH Conference on March 17-18, 2025 - GlobeNewsWire
- 4 months ago - U.S. IPO Weekly Recap: Big Listings Post Mixed Results In Busy 7 IPO Week - Seeking Alpha
- 4 months ago - Odysight.ai Announces the Pricing of $21.5 Million Public Offering and Uplisting to the Nasdaq Capital Market - GlobeNewsWire
- 4 months ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha
- 4 months ago - U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha